Physician profile
John Jacob
NPI 1396009122
$697.52
in general payments reported to CMS, 2019-2025
13 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.68 · 2020: $47.24 · 2021: $26.60 · 2022: $53.34 · 2023: $223 · 2024: $190 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $542.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $204.34 | 2020-2025 | |
| Amgen INC. | $134.77 | 2023-2025 | Evenity, Enbrel, Otezla |
| Aurinia Pharma U.S., INC. | $71.42 | 2021-2024 | Lupkynis |
| Astellas Pharma US INC | $55.54 | 2019-2023 | Veozah |
| Glaxosmithkline, LLC. | $48.78 | 2022-2024 | Arexvy, Shingrix |
| Pfizer INC. | $35.98 | 2022-2024 | |
| Mallinckrodt Hospital Products INC. | $30.36 | 2023 | Acthar |
| Novartis Pharmaceuticals Corporation | $28.84 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.21 | 2023 | |
| Sandoz INC. | $19.56 | 2024 | Hyrimoz |
| Amarin Pharma, INC. | $18.05 | 2020 | |
| Lilly USA, LLC | $15.94 | 2023 | Mounjaro |
| Lucid Diagnostics INC. | $13.73 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.